Differences between a 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 3, 2005, Pages 495-505

  Nergardh R ^a,b   Oerther, S ^a,c   Fredholm, B B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Dopamine; Dopamine agonists; Dopamine D1 receptors; Immediate early gene; In situ hybridization; Locomotion

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BENZAZEPINE DERIVATIVE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 5 RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; ISOCHROMAN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CELL STIMULATION; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG RESPONSE; ENVIRONMENT; GENETIC TRANSFECTION; HABITUATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; STIMULUS RESPONSE;

ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; BODY TEMPERATURE; CHO CELLS; CHROMANS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5;

ANIMALIA;

EID: 29244460636     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.09.017     Document Type: Article

References (44)

1. M.A. Ariano, J. Wang, K.L. Noblett, E.R. Larson, and D.R. Sibley Cellular distribution of the rat D1B receptor in central nervous system using anti-receptor antisera Brain Res 746 1997 141 150
2. 2A adenosine receptor in four PC12 cell clones Naunyn Schmiedebergs Arch Pharmacol 359 1999 28 32
3. W.G. Clark, and J.M. Lipton Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents Neurosci Biobehav Rev 9 1985 299 371
4. J.J. Clifford, O. Tighe, D.T. Croke, A. Kinsella, D.R. Sibley, and J. Drago Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase Neuroscience 93 1999 1483 1489
5. T. Curran, M.B. Gordon, K.L. Rubino, and L.C. Sambucetti Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro Oncogene 2 1987 79 84
6. M.P. DeNinno, R. Schoenleber, R. MacKenzie, D.R. Britton, K.E. Asin, and C. Briggs A68930: a potent agonist selective for the dopamine D1 receptor Eur J Pharmacol 199 1991 209 219
7. R.I. Desai, P. Terry, and J.L. Katz Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists Behav Pharmacol 14 2003 223 228
8. A.M. Deveney, and J.L. Waddington Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists Pharmacol Biochem Behav 58 1997 551 558
9. E. Ericson, J. Samuelsson, and S. Ahlenius Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations J Pharmacol Methods 25 1991 111 122
10. C.R. Gerfen, and W.S. Young Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study Brain Res 460 1988 161 167
11. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, and F.J. Monsma Jr. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
12. J.A. Gingrich, and M.G. Caron Recent advances in the molecular biology of dopamine receptors Annu Rev Neurosci 16 1993 299 321
13. J.A. Gingrich, A. Dearry, P. Falardeau, M.D. Bates, R.T. Fremeau, and M.G. Caron Location and molecular cloning of D1 dopamine receptor Neurochem Int 20 Suppl 1992 9S 15S
14. V. Hillegaart, and S. Ahlenius Time course for synchronization of spontaneous locomotor activity in the rat following reversal of the daylight (12 : 12 h) cycle Physiol Behav 55 1994 73 75
15. A. Holmes, T.R. Hollon, T.C. Gleason, Z. Liu, J. Dreiling, and D.R. Sibley Behavioral characterization of dopamine D5 receptor null mutant mice Behav Neurosci 115 2001 1129 1144
16. R. Isacson, B. Kull, C. Wahlestedt, and P. Salmi A 68930 and dihydrexidine inhibit activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Neuroscience 124 2004 33 42
17. K.R. Jarvie, M. Tiberi, C. Silvia, J.A. Gingrich, and M.G. Caron Molecular cloning, stable expression and desensitization of the human dopamine D1b/D5 receptor J Recept Res 13 1993 573 590
18. 1 receptor Proc Natl Acad Sci U S A 98 2001 9407 9412
19. P.H. Kelly, and S.D. Iversen Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur J Pharmacol 40 1976 45 56
20. T. Kenakin Drug efficacy at G protein-coupled receptors Annu Rev Pharmacol Toxicol 42 2002 349 379
21. Z.U. Khan, A. Gutiérrez, R. Martin, A. Penafiel, A. Rivera, and A. De La Calle Dopamine D5 receptors of rat and human brain Neuroscience 100 2000 689 699
22. C. Le Moine, E. Normand, A.F. Guitteny, B. Fouque, R. Teoule, and B. Bloch Dopamine receptor gene expression by enkephalin neurons in rat forebrain Proc Natl Acad Sci U S A 87 1990 230 234
23. C. Le Moine, P. Svenningsson, B.B. Fredholm, and B. Bloch Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression J Neurosci 17 1997 8038 8048
24. R.R. Luedtke, S.A. Griffin, S.S. Conroy, X. Jin, A. Pinto, and S.R. Sesack Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes J Neuroimmunol 101 1999 170 187
25. Y. Makihara, H. Yamamoto, M. Inoue, K. Tomiyama, N. Koshikawa, and J.L. Waddington Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK and F 82958 as an anomalous agent J Psychopharmacol 18 2004 484 495
26. J. Milbrandt A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor Science 238 1987 797 799
27. D.M. Montague, C.D. Striplin, J.S. Overcash, J. Drago, C.P. Lawler, and R.B. Mailman Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice Synapse 39 2001 319 322
28. S.M. Nicola, J. Surmeier, and R.C. Malenka Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens Annu Rev Neurosci 23 2000 185 215
29. C. Nordstedt, and B.B. Fredholm A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid Anal Biochem 189 1990 231 234
30. K.M. O'Boyle, D.E. Gaitanopoulos, M. Brenner, and J.L. Waddington Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor Neuropharmacology 28 1989 401 405
31. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 4th edn 1998 Academic Press North Ryde, Australia
32. G.V. Rebec, J.R. Christensen, C. Guerra, and M.T. Bardo Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty Brain Res 776 1997 61 67
33. A. Rivera, I. Alberti, A.B. Martín, J.A. Narváez, A. de la Calle, and R. Moratalla Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype Eur J Neurosci 16 2002 2049 2058
34. P. Salmi, and S. Ahlenius Sedative effects of dopamine D1 receptor agonist A 68930 on open-field behavior Neuroreport 11 2000 1269 1272
35. P. Salmi, T. Karlsson, and S. Ahlenius Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat Eur J Pharmacol 253 1994 67 73
36. J.-C. Schwartz, A. Carlsson, M. Caron, B. Scatton, O. Civelli, and J.W. Kebabian Dopamine receptors The IUPHAR compendium of receptor characterization and classification 2000 IUPHAR Media London 171 181 Anonymous
37. D.R. Sibley New insights into dopaminergic receptor function using antisense and genetically altered animals Annu Rev Pharmacol Toxicol 39 1999 313 341
38. 2A receptors. Karolinska Institutet, Stockholm; 1998. p. 1.
39. P. Svenningsson, G.G. Nomikos, and B.B. Fredholm Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration J Neurosci 15 1995 7612 7624
40. P. Svenningsson, R. Nergårdh, and B.B. Fredholm Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat Neuropharmacology 37 1998 331 337
41. P. Svenningsson, B.B. Fredholm, B. Bloch, and C. Le Moine Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons Neuroscience 98 2000 749 757
42. J.L. Waddington, S.A. Daly, R.P. Downes, A.M. Deveney, P.G. McCauley, and K.M. O'Boyle Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors Prog Neuropsychopharmacol Biol Psychiatry 19 1995 811 831
43. J.L. Waddington, J.J. Clifford, F.N. McNamara, K. Tomiyama, N. Koshikawa, and D.T. Croke The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout') Prog Neuropsychopharmacol Biol Psychiatry 25 2001 925 964
44. K. Yoshikawa, C. Williams, and S.L. Sabol Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system J Biol Chem 259 1984 14301 14308